Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study

Higher incidence of acute kidney injury in patients treated with piperacillin/tazobactam than in patients treated with cefepime: a single-center retrospective cohort study

Abstract Background Piperacillin/tazobactam (PIPC/TAZ) and cefepime (CFPM) are commonly used for the treatment of nosocomial and healthcare-associated infections. Recent reports have suggested that the incidence of acute kidney injury (AKI) in patients treated with a combination of vancomycin (VCM)...

Full description

Bibliographic Details
Main Authors: Shota Kadomura, Yoh Takekuma, Yuki Sato, Masato Sumi, Kotaro Kawamoto, Tatsuya Itoh, Mitsuru Sugawara
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Journal of Pharmaceutical Health Care and Sciences
Subjects:
acute kidney injury
nephrotoxicity
piperacillin/tazobactam
cefepime
beta-lactams
Online Access:http://link.springer.com/article/10.1186/s40780-019-0142-6

Internet

http://link.springer.com/article/10.1186/s40780-019-0142-6

Similar Items